fucose/bólga

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

13 niðurstöður

Disaccharide inflammation inhibitors and uses thereof

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of inflammation and carbohydrate and glycoprotein chemistry. More specifically, the present invention relates to novel disaccharide inhibitors of inflammation. 2. Description of the Related

Method of determining a cite of inflammation utilizing elam-1 ligands site

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF THE INVENTION This invention relates generally to determining the presence of and relieving the effects of inflammation. More specifically, this invention relates to carbohydrate ligands which bind to endothelial leukocyte adhesion molecule-1 (hereinafter ELAM-1) and to compositions

Method of treating inflammation by blocking ELAM-1 receptor sites

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Method of determining a site of inflammation utilizing elam-1 ligands

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The present invention relates to novel reducing alkyl-sugar monomers as well as the use thereof as medicaments, in particular as anti-inflammatory agents. The inflammatory reaction is a response by the immune system of an organism faced with an attack against its cells or vascularized tissues by a

Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Method for determination of inflammatory bowel disease

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

TECHNICAL FIELD The instant invention relates to a method for the differential diagnosis of inflammatory bowel disease. In more detail, the instant invention relates to a method for the differential diagnosis between ulcerative colitis and Crohn's disease in a patient with inflammatory bowel

Fucose derivatives, drugs containing the same as active ingredient, and intermediates for producing the same

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

TECHNICAL FIELD The present invention relates to a novel fucose derivative, a drug containing the same as an active ingredient, and an intermediate for producing the same. More particularly, the present invention relates to a novel compound of the formula (I): ##STR3## wherein X.sup.1 is a group of

Selectin binding glycopeptides

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

FIELD OF THE INVENTION This invention relates generally to medicinal chemistry, and preferably to methods of synthesizing and identifying medically useful glyco-amino acids or glycopeptides which are characterized by their capacity to bind to one or more selectins CE-, L-, and

Method for the analysis of N-glycans attached to immunoglobulin G from human blood plasma and its use

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

CROSS REFERENCE TO RELATED APPLICATIONS This application is the U.S. National Phase Application of PCT/HR2014/000022, filed Jun. 11, 2014, which claims priority to Croatian Patent Application No. P20130568A, filed Jun. 20, 2013, the contents of such applications being incorporated by reference

Recombinant protein S composition

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a Protein S composition comprising recombinant Protein S molecules having complex type N-glycoside-linked sugar chains, having a higher binding activity to a receptor for advanced glycation end products

Synthetic core 2-like branched structures containing GalNAc-lewis.sup.x and Neu5Ac.alpha.2-3Gal.beta.1-3GalNAc sequences as novel ligands for selectins

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

TECHNICAL FIELD The invention relates to compounds useful in the treatment of inflammation, allergic reactions, autoimmune diseases, cancer, and similar other conditions that are cell adhesion-dependent. More specifically, the invention concerns compounds, containing GalNAc lewis.sup.x as a mucin

Sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof as well as an anti-inflammatory agent containing the derivative as an effective ingredient thereof. 2.

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum